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1. Introduction 
During in vitro studies on the reduction of 
aromatic acids an enzyme from mycelia of 
Neurospora crassa could be characterised which 
catalyses the formation of differently substituted 
benzoic and cinnamic aldehydes from the correspond- 
ing acids [ 1,2] . In this reaction, besides of the 
transfer of hydrogen from NADPH to the acid, ATP 
was shown to be split into AMP and pyrophosphate 
[3] and not as formerly assumed into ADP and 
orthophosphate. This fact demonstrates that ATP 
serves as the energy donator in this endergonic 
process, suggesting the occurrence of an activated 
intermediate. There was no evidence for a free acyl- 
phosphate or acyl-nucleotide involved in this reaction 
and interest was focused on possibly protein-bound 
intermediates. The results presented in this paper 
give strong evidence for the occurrence of an enzyme- 
nucleotide and an enzyme-acyl intermediate in the 
course of this reaction. 
2. Materials and methods 
Aryl-aldehyde: NADP oxidoreductase was 
purified as described previously [2]. ATP-[-8-14C] 
and ATP-[+32P] as well as auxiliary enzymes and 
coenzymes were purchased from C.F.Boehringer, 
Mannheim. ATP-[Q32P] was prepared according to 
Ives [4]. Salicylate-[-7-14C] was purchased from 
The Radiochemical Center, kmersham. Enzyme- 
substrate complexes were separated from the low 
molecular compounds of the reaction mixture by gel- 
filtration at 4” on 1.5 X 20 cm columns of Sephadex 
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G-50 Fine (Pharmacia) equilibrated in 50 mM Tris- 
HCl, pH 8.0, containing 2mM 2-mercaptoethanol, 
1 mM EDTA, and 5% glycerol. The protein peak, 
marked by the addition of Blue Dextran (Pharmacia) 
to the reaction mixture, was collected in 1 ml 
samples. From aliquots of each fraction radioactivity 
was measured by liquid-scintillation counting in 
Bray’s solution [5] and the amount of enzyme was 
estimated as described previously [2]. 
3. Results 
3.1. Formation of an enzyme-salicylate complex 
The first experiment was on whether an inter- 
mediate nzyme-salicylate is formed during the 
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Fig. 1. Formation of enzyme-salicylate. The reaction mixture 
contained in a fmal volume of 1 ml in rmoles: 100 Tris-HCl, 
pH 8.0, 10 MgClz, 2 dithiothreitol, 0.14 salicylate (2 &i), 
2 ATP (omitted as indicated:, and 0.62 mg enzyme (210 
mu). After incubation at 30 for 10 min the reaction mixture 
was chilled, applied to a Sephadex G-50 column, and 
analysed as described under methods. 
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Enzymesalicylate NADPH Salicylic aldehyde 
added formed 
(dpm) @pm) 
19,700 2,700 
19,700 + 18,500 
To 5 ml of enzyme-salicylate[ 7-14C] (19,700 dpm) were 
added in pmoles: 5 dithiothreitol, 50 MgCla, and 1.7 
NADPH. The reaction mixture was brought to pH 6.8 with 
0.5 ml 1 M potassium phosphate buffer, pH 6.5, giving a 
final volume of 5.8 ml. After incubation at 30’ for 20 min 
0.5 &mole of unlabelled salicylic aldehyde was added. The 
protein was denatured by the addition of 0.4 ml 3 M per- 
chloric acid. The solution was neutralized with 0.4 ml 3 M 
KOH, buffered with 1 ml 1 M phosphate buffer, pH 8.0 and 
extracted twice with 4 ml benzene&her (1 : 1; v/v). The 
organic phase was washed with additional 3 ml of 0.1 M 
phosphate buffer, pH 8.0, and analysed for salicylic aldehyde. 
reaction. Arylaldehyde: NADP oxidoreductase was 
incubated with salicylate-[-7-14C] and the protein 
was isolated as described above. As shown in fig. 1, a 
complex between enzyme and substrate is formed 
only in the presence of ATP. To decide whether this 
compound is a true intermediate of the reaction, the 
salicylate-[T7-14C] labelled complex isolated from the 
Sephadex column was further incubated with and 
without NADPH at pH 6.8. Any formed salicylic 
aldehyde was extracted from the reaction mixture 
and the nature and purity of the product was checked 
by thin-layer chromatography and preparation of the 
2,4dinitrophenylhydrazone. As shown in table 1, 
salicylic aldehyde is formed from enzyme-salicylate 
only in the presence of NADPH; ATP is not necessary 
in this reaction. Therefore, it is evident that the 
enzymic reduction of aromatic acids involves the 
intermediate formation of an enzyme-acyl compound. 
3.2. Formation of an enzyme-nucleotide intermediate 
The next experiments were conducted to study 
the role of ATP in the formation of enzyme-salicylate. 
The enzyme was incubated with either ATP-[-8-14C], 
ATP-[JY-~~P], or ATP-[-Ct.32P] and in each case the 
protein was isolated again by Sephadex gel filtration. 
Labelled protein was obtained only in the case of ATP- 
[-8-14C] (fig. 2), indicating the formation of an 
enzyme-nucleotide compound and excluding the 
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Fig. 2. Formation of enzymenucleotide. The reaction 
mixture contained in pmoles: 50 Tris-HCI, pH 8.0, 10 MgQ, 
2 dithiothreitol, 0.1 ATP (2 PCi), and 0.6 mg enzyme 
(210 mu); in the case of ATP-[p-32P] 1.6 mg enzyme 
(140 mu) was used. Other conditions were as describedin 
fig. 1. 
formation of an phosphorylated or pyrophosphoryl- 
ated enzyme. This finding gives evidence that AMP 
and not ADP is attached upon the enzyme and thus 
may form an activated intermediate. 
4. Discussion 
There are examples for enzyme-AMP compounds 
probably serving as intermediates in enzyme reactions 
(cf [6,7] ). Attempts to prove that the enzyme-AMP 
reported in this paper takes part as an activated 
intermediate in the aryl-aldehyde oxidoreductase 
reaction have so far been unsuccessful. Preliminary 
experiments at different pH values and varied incuba- 
tion conditions failed to demonstrate the formation 
of salicylic aldehyde from enzyme-AMP in the 
presence of salicylate and NADPH. This failure may 
be due to technical difficulties, or the enzyme-AMP 
undergoes structural alterations during its isolation. 
The presented findings suggest hat the enzymic 
reduction of aromatic acids in N. crassa involves 
the formation of an enzyme-AMP and an enzyme 
acyl intermediate. However, we have no knowledge 
as to now about the existence of one common or two 
different binding sites for the nucleotide and the 
acid. Furthermore, it has to be analysed whether the 
acid is bound directly to the protein under the 
release of AMP. Further studies will lead to a better 
understanding of the mechanism of this reaction. 
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